Robert Somerville - Concepedia

Author

Robert Somerville

Also Known As

R P T Somerville, R SOMERVILLE, R Somerville, R. Somerville, Robert P Somerville, Robert P T Somerville, Robert P. Somerville, Robert P. T. Somerville, Robert P.T. Somerville, Robert PT Somerville

184

Publications

11.6K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Cleveland Clinic Center for Cancer Research National Institutes of Health Clinical Center

About

Robert Somerville is an author at National Cancer Institute specializing in medicine, cell biology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	24	5.1K
2	Engineering	3	3	812
3	Natural Sciences	3	3	195
4	Health Sciences	1	1	14
5	Biochemistry	1	1	85

Robert Somerville

Publications

10.9K

Citations

H-Index

Page 1

	Year	Citations
Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer Eric Tran, Simon Turcotte, Alena Gros, Science T-regulatory CellImmunologyPathologyEpithelial CancerImmune Cell Therapy	2014	1.7K
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Journal of Clinical Oncology	2014	1.6K
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer Nikolaos Zacharakis, Harshini Chinnasamy, Mary A. Black, Nature Medicine Durable RegressionMetastatic Breast CancerEngineeringSomatic VariantBreast Oncology	2018	757
Immunogenicity of somatic mutations in human gastrointestinal cancers Eric Tran, Mojgan Ahmadzadeh, Yong‐Chen Lu, Science Cancer ImmunosurveillanceSomatic VariantSomatic MutationsGastrointestinal OncologyHuman Immune System	2015	722
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease Jennifer N. Brudno, Robert Somerville, Victoria Shi, Journal of Clinical Oncology	2016	596
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels James N. Kochenderfer, Robert Somerville, Tangying Lu, Journal of Clinical Oncology	2017	553
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma Stephanie L. Goff, Mark E. Dudley, Deborah E. Citrin, Journal of Clinical Oncology	2016	386
Characterization of ADAMTS-9 and ADAMTS-20 as a Distinct ADAMTS Subfamily Related to Caenorhabditis elegans GON-1 Robert Somerville, Jean‐Michel Longpré, Katherine A. Jungers, Journal of Biological Chemistry	2003	323
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers Maria R. Parkhurst, Paul F. Robbins, Eric Tran, Cancer Discovery	2019	284
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study Smita S. Chandran, Robert Somerville, James C. Yang, The Lancet Oncology OphthalmologyMedicineMelanomaAdoptive TransferDermatology	2017	277

Page 1